LUXEMBOURG, February 02, 2026--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 26/01/2026 | FR0014000MR3 | 5 000 | 70.7336 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 27/01/2026 | FR0014000MR3 | 5 000 | 70.9680 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 28/01/2026 | FR0014000MR3 | 5 000 | 70.5398 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 29/01/2026 | FR0014000MR3 | 5 000 | 67.9096 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 30/01/2026 | FR0014000MR3 | 15 000 | 67.6061 | XPAR |
TOTAL | 35 000 | 68.9956 |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20260202087795/en/
Contacts
Eurofins Scientific SE